BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calcagno DQ, Gigek CO, Chen ES, Burbano RR, Smith MAC. DNA and histone methylation in gastric carcinogenesis. World J Gastroenterol 2013; 19(8): 1182-1192 [PMID: 23482412 DOI: 10.3748/wjg.v19.i8.1182] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 84] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Loe AKH, Zhu L, Kim TH. Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis. Exp Mol Med 2023;55:22-31. [PMID: 36653445 DOI: 10.1038/s12276-023-00926-0] [Reference Citation Analysis]
2 Loren P, Lugones Y, Saavedra N, Saavedra K, Páez I, Rodriguez N, Moriel P, Salazar LA. MicroRNAs Involved in Intrinsic Apoptotic Pathway during Cisplatin-Induced Nephrotoxicity: Potential Use of Natural Products against DDP-Induced Apoptosis. Biomolecules 2022;12:1206. [DOI: 10.3390/biom12091206] [Reference Citation Analysis]
3 Zhao T, Yang T, Zhang J, Hao H, Wang D, Afirifa J, Cai M, Cui X, Bai J, Fu S, Yu J. The promoter methylation drives down-regulation mode of HIC1 in gastric cancer, its molecular characteristics and downstream functional pathways. Gene 2022;824:146380. [PMID: 35276239 DOI: 10.1016/j.gene.2022.146380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang Y, Tao G, Liu P, Lu K, Han Z, Liu H, Du M, Wang M, Chu H, Zhang Z. Evaluation of genetic variants in nucleosome remodeling and deacetylase (NuRD) complex subunits encoding genes and gastric cancer susceptibility. Arch Toxicol 2022. [PMID: 35362730 DOI: 10.1007/s00204-022-03275-5] [Reference Citation Analysis]
5 Zhang W, Cui N, Ye J, Yang B, Sun Y, Kuang H. Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism. Chinese Herbal Medicines 2022. [DOI: 10.1016/j.chmed.2021.11.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jing L, Kwok HF. The intricate roles of RCC1 in normal cells and cancer cells. Biochem Soc Trans 2022:BST20210861. [PMID: 35191966 DOI: 10.1042/BST20210861] [Reference Citation Analysis]
7 Zhang S, Zhang J, Zhang Q, Liang Y, Du Y, Wang G. Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile. Front Cell Dev Biol 2022;9:817086. [DOI: 10.3389/fcell.2021.817086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Teng JJ, Zhao WJ, Zhang XL, Zhao DK, Qiu XY, Chen XD, Yang L. Downregulation of promoter methylation gene PRDM5 contributes to the development of tumor proliferation and predicts poor prognosis in gastric cancer. J Cancer 2021;12:6921-30. [PMID: 34659579 DOI: 10.7150/jca.59998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hu D, Lou X, Meng N, Li Z, Teng Y, Zou Y, Wang F. Peripheral Blood-Based DNA Methylation of Long Non-Coding RNA H19 and Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promoters are Potential Non-Invasive Biomarkers for Gastric Cancer Detection. Cancer Control 2021;28:10732748211043667. [PMID: 34615385 DOI: 10.1177/10732748211043667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Tan S, Gui W, Wang S, Sun C, Xu X, Liu L. A methylation-based prognostic model predicts survival in patients with colorectal cancer. J Gastrointest Oncol 2021;12:1590-600. [PMID: 34532113 DOI: 10.21037/jgo-21-376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dobre EG, Constantin C, Costache M, Neagu M. Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma. J Pers Med 2021;11:901. [PMID: 34575678 DOI: 10.3390/jpm11090901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Yao X, Hao S, Xue T, Zhou K, Zhang Y, Li H. Association of HOTAIR Polymorphisms with Susceptibility to Psoriasis in a Chinese Han Population. Biomed Res Int 2021;2021:5522075. [PMID: 34395618 DOI: 10.1155/2021/5522075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Shetty NP, Prabhakaran M, Srivastava AK. Pleiotropic nature of curcumin in targeting multiple apoptotic-mediated factors and related strategies to treat gastric cancer: A review. Phytother Res 2021. [PMID: 34028111 DOI: 10.1002/ptr.7158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Loren P, Saavedra N, Saavedra K, Zambrano T, Moriel P, Salazar LA. Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update. Pharmaceuticals (Basel) 2021;14:491. [PMID: 34063951 DOI: 10.3390/ph14060491] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
15 Qu Y, Gao N, Wu T. Expression and clinical significance of SYNE1 and MAGI2 gene promoter methylation in gastric cancer. Medicine (Baltimore) 2021;100:e23788. [PMID: 33530176 DOI: 10.1097/MD.0000000000023788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Vahidi S, Samadani AA. TERRA Gene Expression in Gastric Cancer: Role of hTERT. J Gastrointest Cancer 2021;52:431-47. [PMID: 33411257 DOI: 10.1007/s12029-020-00565-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Dutta A, Datta S, Snehlata. Epigenetic regulations in gastrointestine: Implications on sensitivity to ionizing radiation, inflammatory diseases, and cancer development. Epigenetics and Metabolomics 2021. [DOI: 10.1016/b978-0-323-85652-2.00011-7] [Reference Citation Analysis]
18 Zhang Y, Guo D. Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma. Front Genet 2020;11:551787. [PMID: 33363566 DOI: 10.3389/fgene.2020.551787] [Reference Citation Analysis]
19 Nissar B, Shah IA, ul Afshan F, Ganai BA. A decade in unravelling the etiology of gastric carcinogenesis in Kashmir, India – A high risk region. Gene Reports 2020;21:100832. [DOI: 10.1016/j.genrep.2020.100832] [Reference Citation Analysis]
20 Deiva Suga SS, Krishna Mohan S, Sreekandan RN, K M, Kamaraj D, Veeraraghavan VP, Jayaraman S, Rajagopal P. Molecular docking analysis of phytocompounds from Andrographis paniculata binding with proteins in the notch-signaling pathway. Bioinformation 2020;16:923-8. [PMID: 34803268 DOI: 10.6026/97320630016923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Ullah MF, Usmani S, Shah A, Abuduhier FM. Dietary molecules and experimental evidence of epigenetic influence in cancer chemoprevention: An insight. Semin Cancer Biol 2020:S1044-579X(20)30216-9. [PMID: 33152485 DOI: 10.1016/j.semcancer.2020.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Sadeghi-Amiri L, Barzegar A, Nikbakhsh-Zati N, Mehraban P. Hypomethylation of the XRE -1383 site is associated with the upregulation of CYP1A1 in gastric adenocarcinoma. Gene 2021;769:145216. [PMID: 33069801 DOI: 10.1016/j.gene.2020.145216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Yamamoto H, Watanabe Y, Sato Y, Maehata T, Itoh F. Non-Invasive Early Molecular Detection of Gastric Cancers. Cancers (Basel) 2020;12:E2880. [PMID: 33036473 DOI: 10.3390/cancers12102880] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
24 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
25 Li Y, Sun R, Zhang Y, Yuan Y, Miao Y. A methylation-based mRNA signature predicts survival in patients with gastric cancer. Cancer Cell Int 2020;20:284. [PMID: 32647495 DOI: 10.1186/s12935-020-01374-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Liu W, Luo B. The impact of EBV on the epigenetics of gastric carcinoma. Future Virology 2020;15:183-93. [DOI: 10.2217/fvl-2019-0148] [Reference Citation Analysis]
27 Peng Y, Wu Q, Wang L, Wang H, Yin F. A DNA methylation signature to improve survival prediction of gastric cancer. Clin Epigenetics 2020;12:15. [PMID: 31959204 DOI: 10.1186/s13148-020-0807-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
28 Zhang C, Wei S, Hu J, Xiong Z. Upregulated expression of G9a is correlated with poor prognosis of gastric cancer patients. Medicine (Baltimore) 2019;98:e18212. [PMID: 31770281 DOI: 10.1097/MD.0000000000018212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Zhou H, Sun H, Liu X, Chen J, Zhang L, Lin S, Han X, Nie C, Liu Y, Tian W, Zhao Y. Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer. Helicobacter 2019;24:e12650. [PMID: 31361067 DOI: 10.1111/hel.12650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Hu S, Yin X, Zhang G, Meng F. Identification of DNA methylation signature to predict prognosis in gastric adenocarcinoma. J Cell Biochem 2019;120:11708-15. [PMID: 30775802 DOI: 10.1002/jcb.28450] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
31 Bure IV, Nemtsova MV, Zaletaev DV. Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer. Int J Mol Sci 2019;20:E2870. [PMID: 31212809 DOI: 10.3390/ijms20122870] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 12.5] [Reference Citation Analysis]
32 Calcagno DQ, Wisnieski F, Mota ERDS, Maia de Sousa SB, Costa da Silva JM, Leal MF, Gigek CO, Santos LC, Rasmussen LT, Assumpção PP, Burbano RR, Smith MA. Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives. Epigenomics 2019;11:349-62. [DOI: 10.2217/epi-2018-0081] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
33 Gigek CO, Chen ES, Smith MAC. Epigenetic Alterations in Stomach Cancer: Implications for Diet and Nutrition. Handbook of Nutrition, Diet, and Epigenetics 2019. [DOI: 10.1007/978-3-319-55530-0_29] [Reference Citation Analysis]
34 Ye X, Zhang R, Lian F, Zhang W, Lu W, Han J, Zhang N, Jin J, Luo C, Chen K, Ye F, Ding H. The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening. Bioorg Med Chem Lett 2019;29:638-45. [PMID: 30626558 DOI: 10.1016/j.bmcl.2018.12.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
35 Barati N, Momtazi-Borojeni AA, Majeed M, Sahebkar A. Potential therapeutic effects of curcumin in gastric cancer. J Cell Physiol 2019;234:2317-28. [PMID: 30191991 DOI: 10.1002/jcp.27229] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
36 Ghadami E, Nikbakhsh N, Fattahi S, Kosari‐monfared M, Ranaee M, Taheri H, Amjadi‐moheb F, Godazandeh G, Shafaei S, Nosrati A, Pilehchian Langroudi M, Samadani AA, Amirbozorgi G, Mirnia V, Akhavan‐niaki H. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections. J Cell Physiol 2019;234:4115-24. [DOI: 10.1002/jcp.27220] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
37 Shi Y, Chen Z, Gao J, Wu S, Gao H, Feng G. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma. Oncol Rep 2018;40:2014-22. [PMID: 30106437 DOI: 10.3892/or.2018.6623] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Li W, Wong CC, Zhang X, Kang W, Nakatsu G, Zhao Q, Chen H, Go MYY, Chiu PWY, Wang X, Ji J, Li X, Cai Z, Ng EKW, Yu J. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis. Oncogene 2018;37:6383-98. [PMID: 30054562 DOI: 10.1038/s41388-018-0402-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
39 Cui H, Hu Y, Guo D, Zhang A, Gu Y, Zhang S, Zhao C, Gong P, Shen X, Li Y, Wu H, Wang L, Zhao Z, Fan H. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer. Oncogene. 2018;37:4358-4371. [PMID: 29717263 DOI: 10.1038/s41388-018-0285-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
40 Shen S, Chen X, Li H, Sun L, Yuan Y. MLH1 Promoter Methylation and Prediction/Prognosis of Gastric Cancer: A Systematic Review and Meta and Bioinformatic Analysis. J Cancer 2018;9:1932-42. [PMID: 29896277 DOI: 10.7150/jca.23284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
41 Chen X, Yang Y, Liu J, Li B, Xu Y, Li C, Xu Q, Liu G, Chen Y, Ying J, Duan S. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population. Oncotarget 2017;8:8105-19. [PMID: 28042954 DOI: 10.18632/oncotarget.14099] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
42 Woo SM, Seo SU, Min KJ, Kwon TK. BIX-01294 sensitizes renal cancer Caki cells to TRAIL-induced apoptosis through downregulation of survivin expression and upregulation of DR5 expression. Cell Death Discov 2018;4:29. [PMID: 29531826 DOI: 10.1038/s41420-018-0035-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
43 Shao L, Chen Z, Peng D, Soutto M, Zhu S, Bates A, Zhang S, El-Rifai W. Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells. Mol Cancer Res 2018;16:696-706. [PMID: 29453320 DOI: 10.1158/1541-7786.MCR-17-0655] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
44 Montenegro RC, Clark PG, Howarth A, Wan X, Ceroni A, Siejka P, Nunez-Alonso GA, Monteiro O, Rogers C, Gamble V, Burbano R, Brennan PE, Tallant C, Ebner D, Fedorov O, O'Neill E, Knapp S, Dixon D, Müller S. BET inhibition as a new strategy for the treatment of gastric cancer. Oncotarget 2016;7:43997-4012. [PMID: 27259267 DOI: 10.18632/oncotarget.9766] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
45 Pang L, Li JF, Su L, Zang M, Fan Z, Yu B, Wu X, Li C, Yan M, Zhu ZG, Liu B. ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway. J Gastroenterol 2018;53:71-83. [PMID: 28315004 DOI: 10.1007/s00535-017-1329-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
46 Gigek CO, Calcagno DQ, Rasmussen LT, Santos LC, Leal MF, Wisnieski F, Burbano RR, Lourenço LG, Lopes-Filho GJ, Smith MAC. Genetic variants in gastric cancer: Risks and clinical implications. Exp Mol Pathol 2017;103:101-11. [PMID: 28736214 DOI: 10.1016/j.yexmp.2017.07.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
47 Yao Y, Ni Y, Zhang J, Wang H, Shao S. The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets. Oncotarget 2017;8:53839-53. [PMID: 28881855 DOI: 10.18632/oncotarget.17809] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
48 Wang Z, Chen G, Wang Q, Lu W, Xu M. Identification and validation of a prognostic 9-genes expression signature for gastric cancer. Oncotarget. 2017;8:73826-73836. [PMID: 29088749 DOI: 10.18632/oncotarget.17764] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
49 Hung PS, Chen CY, Chen WT, Kuo CY, Fang WL, Huang KH, Chiu PC, Lo SS. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma. PLoS One. 2017;12:e0177346. [PMID: 28486502 DOI: 10.1371/journal.pone.0177346] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
50 Patel TN, Roy S, Ravi R. Gastric cancer and related epigenetic alterations. Ecancermedicalscience. 2017;11:714. [PMID: 28144288 DOI: 10.3332/ecancer.2017.714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
51 Gigek CO, Chen ES, Smith MAC. Epigenetic Alterations in Stomach Cancer: Implications for Diet and Nutrition. Handbook of Nutrition, Diet, and Epigenetics 2017. [DOI: 10.1007/978-3-319-31143-2_29-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 da Silva Oliveira KC, Thomaz Araújo TM, Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F, Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, Rodriguez Burbano RM, Smith MC, Calcagno DQ. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol 2016; 22(35): 7951-7962 [PMID: 27672290 DOI: 10.3748/wjg.v22.i35.7951] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
53 Cureau N, Aljahdali N, Vo N, Carbonero F. Epigenetic mechanisms in microbial members of the human microbiota: current knowledge and perspectives. Epigenomics 2016;8:1259-73. [DOI: 10.2217/epi-2016-0057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
54 Samadani AA, Nikbakhsh N, Pilehchian M, Fattahi S, Akhavan-Niaki H. Epigenetic changes of CDX2 in gastric adenocarcinoma. J Cell Commun Signal 2016;10:267-72. [PMID: 27139434 DOI: 10.1007/s12079-016-0327-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
55 Xue WJ, Feng Y, Wang F, Li P, Liu YF, Guo YB, Wang ZW, Mao QS. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer. Tumour Biol 2016;37:11249-57. [PMID: 26945573 DOI: 10.1007/s13277-016-5001-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
56 Babacan NA, Egilmez HR, Yücel B, Ilknur P, Seker MM, Kacan T, Bahceci A, Cihan S, Akinci B, Eriten B, Kilickap S. The prognostic value of UHRF-1 and p53 in gastric cancer. Saudi J Gastroenterol 2016;22:25-9. [PMID: 26831603 DOI: 10.4103/1319-3767.173755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
57 Deng J, Liang H, Ying G, Dong Q, Zhang R, Yu J, Fan D, Hao X. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer. Oncotarget 2015;6:4482-95. [PMID: 25714013 DOI: 10.18632/oncotarget.2916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
58 Libânio D, Dinis-Ribeiro M, Pimentel-Nunes P. Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol 2015; 6(5): 111-132 [PMID: 26468448 DOI: 10.5306/wjco.v6.i5.111] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
59 Hudler P. Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol 2015; 21(37): 10510-10527 [PMID: 26457012 DOI: 10.3748/wjg.v21.i37.10510] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
60 Kanda M, Kodera Y. Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol 2015; 21(34): 9838-9852 [PMID: 26379391 DOI: 10.3748/wjg.v21.i34.9838] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 84] [Article Influence: 9.0] [Reference Citation Analysis]
61 Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics. 2015;7:475-486. [PMID: 26077432 DOI: 10.2217/epi.15.4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 11.9] [Reference Citation Analysis]
62 Farid SG, Morris-Stiff G. "OMICS" technologies and their role in foregut primary malignancies. Curr Probl Surg. 2015;52:409-441. [PMID: 26527526 DOI: 10.1067/j.cpsurg.2015.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
63 Wang Z, Zhu L, Guo T, Wang Y, Yang J. Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma. Human Pathology 2015;46:1006-14. [DOI: 10.1016/j.humpath.2015.04.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
64 Yamamoto H, Imai K. Microsatellite instability: an update. Arch Toxicol. 2015;89:899-921. [PMID: 25701956 DOI: 10.1007/s00204-015-1474-0] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 14.9] [Reference Citation Analysis]
65 Ren A, Qiu Y, Cui H, Fu G. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma. Biochem Biophys Res Commun 2015;459:10-7. [PMID: 25634693 DOI: 10.1016/j.bbrc.2015.01.068] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
66 Calcagno DQ, de Arruda Cardoso Smith M, Burbano RR. Cancer type-specific epigenetic changes: gastric cancer. Methods Mol Biol 2015;1238:79-101. [PMID: 25421656 DOI: 10.1007/978-1-4939-1804-1_5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
67 McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11:664-74. [PMID: 25134511 DOI: 10.1038/nrgastro.2014.143] [Cited by in Crossref: 250] [Cited by in F6Publishing: 271] [Article Influence: 27.8] [Reference Citation Analysis]
68 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 71] [Article Influence: 7.2] [Reference Citation Analysis]
69 Ke XX, Zhang D, Zhu S, Xia Q, Xiang Z, Cui H. Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS One. 2014;9:e106962. [PMID: 25198515 DOI: 10.1371/journal.pone.0106962] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
70 Qiang-long Z, Shi L, Peng G, Fei-shi L. High-throughput Sequencing Technology and Its Application. Journal of Northeast Agricultural University (English Edition) 2014;21:84-96. [DOI: 10.1016/s1006-8104(14)60073-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
71 Bai Y, Fang N, Gu T, Kang Y, Wu J, Yang D, Zhang H, Suo Z, Ji S. HOXA11 gene is hypermethylation and aberrant expression in gastric cancer. Cancer Cell Int 2014;14:79. [PMID: 25788862 DOI: 10.1186/s12935-014-0079-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
72 Cao XY, Ma HX, Shang YH, Jin MS, Kong F, Jia ZF, Cao DH, Wang YP, Suo J, Jiang J. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer. World J Gastroenterol 2014; 20(25): 8201-8208 [PMID: 25009393 DOI: 10.3748/wjg.v20.i25.8201] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
73 Yamamoto H, Watanabe Y, Maehata T, Morita R, Yoshida Y, Oikawa R, Ishigooka S, Ozawa SI, Matsuo Y, Hosoya K, Yamashita M, Taniguchi H, Nosho K, Suzuki H, Yasuda H, Shinomura Y, Itoh F. An updated review of gastric cancer in the next-generation sequencing era: Insights from bench to bedside and vice versaWorld J Gastroenterol 2014; 20(14): 3927-3937 [PMID: 24744582 DOI: 10.3748/wjg.v20.i14.3927] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
74 Frycz BA, Murawa D, Borejsza-Wysocki M, Marciniak R, Murawa P, Drews M, Kołodziejczak A, Tomela K, Jagodziński PP. Decreased expression of ten-eleven translocation 1 protein is associated with some clinicopathological features in gastric cancer. Biomed Pharmacother. 2014;68:209-212. [PMID: 24507562 DOI: 10.1016/j.biopha.2013.12.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
75 Masih S, Plumptre LA, Kim Y. One-Carbon Metabolism Nutrients and Epigenetics: A Mechanistic Link Between Aberrant One-Carbon Metabolism and Cancer Risk? Molecular mechanisms and physiology of disease 2014. [DOI: 10.1007/978-1-4939-0706-9_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Pontes TB, Chen ES, Gigek CO, Calcagno DQ, Wisnieski F, Leal MF, Demachki S, Assumpção PP, Artigiani R, Lourenço LG, Burbano RR, Arruda Cardoso Smith M. Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis. Tumor Biol 2014;35:3447-53. [DOI: 10.1007/s13277-013-1455-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
77 Wang ZJ, Yang JL, Wang YP, Lou JY, Chen J, Liu C, Guo LD. Decreased histone H2B monoubiquitination in malignant gastric carcinoma. World J Gastroenterol 2013; 19(44): 8099-8107 [PMID: 24307806 DOI: 10.3748/wjg.v19.i44.8099] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
78 Yang Q, Gao J, Xu L, Zeng Z, Sung JJ, Yu J. Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer. Biomarkers. 2013;18:721-725. [PMID: 24191714 DOI: 10.3109/1354750x.2013.853839] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
79 Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta. 2013;424:53-65. [PMID: 23669186 DOI: 10.1016/j.cca.2013.05.002] [Cited by in Crossref: 228] [Cited by in F6Publishing: 211] [Article Influence: 22.8] [Reference Citation Analysis]